Author

Dr. Sydney Kertzmann

Latest reporting and analysis by Dr. Sydney Kertzmann.

Page 2 32 stories total More updates ahead
Akamai Stock Rises After Morgan Stanley Double Upgrade

Akamai Stock Rises After Morgan Stanley Double Upgrade

Akamai Technologies shares gained 3.5% on Jan. 12 following a rare double upgrade by Morgan Stanley, which raised its price target to $115. The company reported Q3 2025 revenue growth of 5% year-over-year, with security revenue up 10%.

Waystar Emerges as Top AI Pick in Healthcare Software Shift

Waystar Emerges as Top AI Pick in Healthcare Software Shift

Bank of America analyst Allen Lutz names Waystar as a top 2026 pick, citing its position at the intersection of high-growth software and administrative bottlenecks. The company's AI tools and aggressive consolidation strategy are highlighted amid industry changes following the Change Healthcare cyberattack.